Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines

Carcinogenesis

Volumn 30, Issue 8, 2009, Pages 1433-1442

  Sloan, Karin A ^a   Marquez, Hector A ^a   Li, Jun ^a   Cao, Yuxia ^a   Hinds, Anne ^a   O'Hara, Carl J ^a   Kathuria, Satinder ^b   Ramirez, Maria I ^a   Williams, Mary C ^a   Kathuria, Hasmeena ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; ERYTHROBLASTOSIS VIRUS TRANSFORMING SEQUENCE; ONCOPROTEIN; PROTEIN CALU; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELK 3; TRANSCRIPTION FACTOR PEA3; UNCLASSIFIED DRUG; VIRUS PROTEIN; CAV1 PROTEIN, HUMAN; ELK3 PROTEIN, HUMAN; LUCIFERASE; MESSENGER RNA; NORADRENALIN TRANSPORTER; SLC6A2 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SEQUENCE HOMOLOGY; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR DIFFERENTIATION; CELL NUCLEUS; CYTOPLASM; DISEASE COURSE; DRUG ANTAGONISM; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; TUMOR CELL CULTURE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CAVEOLIN 1; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CYTOPLASM; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LUCIFERASES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; ONCOGENE PROTEINS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED;

EID: 69449107486     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp129     Document Type: Article

References (53)

1. Williams, T. M. et al. (2005) Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am. J. Physiol. Cell Physiol. 288, C494-C506.
2. Wikman, H. et al. (2002) Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene, 21, 5804-5813.
3. Powell, C. A. et al. (2003) Gene expression in lung adenocarcinomas of smokers and nonsmokers. Am. J. Respir. Cell. Mol. Biol., 29, 157-162.
4. Ho, C. C. et al. (2002) Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am. J. Pathol., 161, 1647-1656.
5. Kato, T. et al. (2004) Difference of caveolin-1 expression pattern in human lung neoplastic tissue. Atypical adenomatous hyperplasia, adenocarcinoma and squamous cell carcinoma. Cancer Lett., 214 121-128.
6. Quest, A. et al. (2008) Caveolin-1, an ambiguous partner in cell signaling and cancer. J. Cell. Mol. Med., 12, 1130-1150.
7. Galbiati, F. et al. (2001) Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/ p21(WAF1/Cip1)-dependent mechanism. Mol. Biol. Cell, 12, 2229-2244.
8. Williams, T. M. et al. (2004) Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J. Biol. Chem., 279, 51630-51646.
9. Capozza, F. et al. (2003) Absence of caveolin-1 sensitizes mouse skin to carcinogen-induced epidermal hyperplasia and tumor formation. Am. J. Pathol., 162, 2029-2039.
10. Engelman, J. A. et al. (1998) Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31. 1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett., 436, 403-410.
11. Torres, V. A. et al. (2007) E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription. Mol. Cell. Biol., 27, 7703-7717.
12. Williams, T. M. et al. (2005) Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: Genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice. J. Biol. Chem., 280, 25134-25145.
13. Kathuria, H. et al. (2004) Transcription of the caveolin-1 gene is differentially regulated in lung type I epithelial and endothelial cell lines. A role for ETS proteins in epithelial cell expression. J. Biol. Chem., 279, 30028-30036.
14. Kathuria, H. et al. (2007) ERM is expressed by alveolar epithelial cells in adult mouse lung and regulates caveolin-1 transcription in mouse lung epithelial cell lines. J. Cell. Biochem., 102, 13-27.
15. Tirado, O. M. et al. (2006) Caveolin-1 (CAV1) is a target of EWS/ FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells. Cancer Res., 66, 9937-9947.
16. van Riggelen, J. et al. (2005) Loss of net as repressor leads to constitutive increased c-fos transcription in cervical cancer cells. J. Biol. Chem., 280, 3286-3294.
17. Liu, Y. et al. (2003) Role for ETS domain transcription factors Pea3/Erm in mouse lung development. Dev. Biol., 261, 10-24.
18. Hollenhorst, P. C. et al. (2004) Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors. Nucleic Acids Res., 32, 5693-5702.
19. Hiroumi, H. et al. (2001) Expression of E1AF/PEA3, an Ets-related transcription factor in human non-small-cell lung cancers: Its relevance in cell motility and invasion. Int. J. Cancer, 93, 786-791.
20. Sharrocks, A. D. (2001) The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol., 2, 827-837.
21. Eo, J. et al. (2008) ERM, an ETS transcription factor, is expressed in granulosa and cumulus cells and serves as a transcriptional regulator of the cyclooxygenase-2. J. Endocrinol., 198, 281-290.
22. Turner, D. P. et al. (2007) Defining ETS transcription regulatory networks and their contribution to breast cancer progression. J. Cell. Biochem., 102, 549-559.
23. Cowden Dahl, K. D. et al. (2007) PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells. Mol. Cancer Res., 5, 413-421.
24. Mercer, B. A. et al. (2009) Identification of a cigarette smoke-responsive region in the distal MMP-1 promoter. Am. J. Respir. Cell. Mol. Biol., 40, 4-12.
25. Travis, W. D. et al. (1999) World Health Organization International Histological Classification of Tumors: Histologic typing of lung and pleural tumors. 3rd edn. Springer, New York, NY.
26. Kaufmann, O. et al. (2000) Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Histopathology, 36, 8-16.
27. Ge, S. et al. (2006) Fluorescent immunohistochemistry and in situ hybridization analysis of mouse pancreas using low-power antigen-retrieval technique. J. Histochem. Cytochem., 54, 843-847.
28. Namimatsu, S. et al. (2005) Reversing the effects of formalin fixation with citraconic anhydride and heat: A universal antigen retrieval method. J. Histochem. Cytochem., 53, 3-11.
29. Racine, C. et al. (1999) Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Biochem. Biophys. Res. Commun., 255, 580-586.
30. Sunaga, N. et al. (2004) Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Cancer Res., 64, 4277-4285.
31. de Launoit, Y. et al. (2006) The Ets transcription factors of the PEA3 group: Transcriptional regulators inmetastasis. Biochim. Biophys. Acta, 1766, 79-131.
32. Hakuma, N. et al. (2005) E1AF/PEA3 activates the Rho/ Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells. Cancer Res., 65, 10776-10782.
33. Upadhyay, S. et al. (2006) LKB1/STK11 suppresses cyclooxygenase-2 induction and cellular invasion through PEA3 in lung cancer. Cancer Res., 66, 7870-7879.
34. Cui, J. et al. (2001) Hypermethylation of the caveolin-1 gene promoter in prostate cancer. Prostate, 46, 249-256.
35. Engelman, J. A. et al. (1999) Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31. 1). Methylation of a CpG island in the 5′ promoter region of the caveolin-1 gene in human breast cancer cell lines. FEBS Lett., 448, 221-230.
36. Lin, S. Y. et al. (2004) Promoter CpG methylation of caveolin-1 in sporadic colorectal cancer. Anticancer Res., 24, 1645-1650.
37. Wiechen, K. et al. (2001) Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am. J. Pathol., 159, 1635-1643.
38. Hayashi, K. et al. (2001) Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res., 61, 2361-2364.
39. Ayadi, A. et al. (2001) Net, an Ets ternary complex transcription factor, is expressed in sites of vasculogenesis, angiogenesis, and chondrogenesis during mouse development. Mech. Dev., 102, 205-208.
40. Ducret, C. et al. (2000) The ternary complex factor Net contains two distinct elements that mediate different responses to MAP kinase signalling cascades. Oncogene, 19, 5063-5072.
41. Buchwalter, G. et al. (2004) Ets ternary complex transcription factors. Gene, 324, 1-14.
42. Zheng, H. et al. (2003) The transcription factor Net regulates the angiogenic switch. Genes Dev., 17, 2283-2297.
43. Lamber, E. P. et al. (2008) Regulation of the transcription factor Ets-1 by DNA-mediated homo-dimerization. EMBO J, 27, 2006-2017.
44. Bist, A. et al. (1997) Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. Proc. Natl Acad. Sci. USA, 94, 10693-10698.
45. Bist, A. et al. (2000) p53 regulates caveolin gene transcription, cell cholesterol, and growth by a novel mechanism. Biochemistry, 39, 1966-1972.
46. Roy, U. K. et al. (2008) Wild-type APC regulates caveolin-1 expression in human colon adenocarcinoma cell lines via FOXO1a and C-myc. Mol. Carcinog., 47, 947-955.
47. Salnikow, K. et al. (2008) Regulation of hypoxia-inducible genes by ETS1 transcription factor. Carcinogenesis, 29, 1493-1499.
48. Yamaguchi, E. et al. (2007) Ets-1 proto-oncogene as a potential predictor for poor prognosis of lung adenocarcinoma. Tohoku J. Exp. Med., 213, 41-50.
49. Soda, M. et al. (2007) Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature, 448, 561-566.
50. Helgeson, B. E. et al. (2008) Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Cancer Res., 68 73-80.
51. Tognon, C. et al. (2002) Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2, 367-376.
52. Shimizu, K. et al. (1993) An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. Proc. Natl Acad. Sci. USA, 90, 10280-10284.
53. Sethi, G. et al. (2008) Nuclear factor-kappaB activation: From bench to bedside. Exp. Biol. Med., 233, 21-31.